Dr. Kooresh Isaac Shoghi's lab focuses on improving treatment options for patients with advanced breast cancer by studying how certain therapies work with estrogen receptors. Specifically, they investigate the use of PET imaging to predict which patients might benefit from hormone therapies instead of more aggressive treatments like chemotherapy. This research aims to make cancer treatment more personalized and effective for patients with hormone-sensitive breast cancer.

Dr. Jonathan Kipnis's lab at Washington University focuses on understanding how the immune system influences brain function and contributes to age-related cognitive decline and diseases like Alzheimer's. The research explores the role of meningeal lymphatics and immune cells in maintaining cognitive health, especially in older adults. The lab aims to develop innovative treatments that may enhance brain health by modulating immune responses.

Nathaniel Huebsch's laboratory at Washington University focuses on combining advanced computational methods and smart materials to create innovative systems that simulate how mechanical forces affect tissues. By integrating real-time monitoring and control of tissue environments, the lab aims to improve drug screening processes and enhance the understanding of mechanobiology. This work has the potential to significantly impact how drug effects are studied, making them more applicable to real-life clinical scenarios.

Dr. Zachariah Meadows Reagh's research lab at Washington University focuses on understanding how aging, particularly in individuals at risk for Alzheimer's disease, affects memory. The lab explores the nuances of episodic memory, including how different features of memories are impacted by aging, and how these changes relate to brain network dysfunction. Through innovative behavioral tests and advanced imaging techniques, the lab aims to make significant contributions to our understanding of memory decline and to inform future clinical assessments and treatments.

Dr. Muriah D. Wheelock's research lab focuses on understanding how early brain development impacts neurological health later in life, particularly in relation to Alzheimer's disease and other neurodegenerative disorders. The lab studies brain functional connectivity in infants and toddlers to explore how early life experiences and conditions, such as low birth weight or trauma, influence brain development and long-term health outcomes. By analyzing brain imaging data and employing advanced techniques, the lab aims to uncover critical patterns that can inform prevention and intervention strategies for childhood development and aging.

Dr. Zhude Tu's research lab focuses on understanding neuroinflammation in neurodegenerative diseases such as Parkinson's disease and multiple sclerosis. Using advanced imaging techniques like positron emission tomography (PET), the lab aims to develop new radiotracers to visualize critical receptors involved in inflammation. This work not only seeks to identify biomarkers for these conditions but also explores potential therapeutic targets to improve treatment outcomes.

Dr. Aditi Gupta's lab focuses on improving the care of individuals with Neurofibromatosis Type 1 (NF1) using innovative artificial intelligence techniques. By analyzing a wide range of clinical data, the lab aims to develop predictive models to assess disease risk associated with various NF1-related sub-phenotypes. This research intends to enhance the precision of diagnosis and the personalization of treatment options for patients affected by NF1.

Dr. David Gutmann's lab focuses on understanding neurofibromatosis type 1 (NF1) and its impact on brain tumors and neurodevelopmental problems in children. They aim to uncover the biological mechanisms behind NF1-related conditions to improve treatment strategies and patient outcomes. The lab utilizes integrative approaches, combining patient-derived cells, advanced genetic techniques, and mouse models to explore how different cell types interact in these diseases.

Dr. Michael Benjamin Major's lab at Washington University explores innovative treatments for head and neck cancers, focusing on a protein called NRF2 that helps tumors resist radiation therapy. The team is testing new drugs that inhibit NRF2 to make these cancers more sensitive to radiation, aiming to improve patient outcomes. This research holds the potential to significantly enhance the effectiveness of existing cancer treatments and provide new therapeutic strategies for challenging cases.

Dr. Carolina B. Lopez's lab at Washington University focuses on understanding how respiratory viruses, particularly the respiratory syncytial virus (RSV) and parainfluenza viruses, contribute to viral infections and chronic lung diseases. The lab investigates the role of defective viral genomes in disease severity and seeks to explore the long-term impacts of these viral infections on respiratory health. By studying how viruses persist in the body after initial infection, the lab aims to find new ways to reduce the public health burden caused by these common infections.

Dr. Polina Lishko's lab at Washington University focuses on understanding how sperm function is regulated, particularly through a calcium channel called CatSper, which is critical for male fertility. The lab studies how environmental factors like temperature and certain chemicals influence sperm motility and capacitation—the process that enables sperm to fertilize an egg. Their research has important implications for addressing male infertility issues, such as those associated with varicocele, a condition that can impair sperm function.

Professor Michele Leroux’s research focuses on the fascinating interactions between bacteria and viruses, specifically how bacteria protect themselves from viral infections using a process called ADP-ribosylation. This modification helps bacteria disable viral DNA, and her lab investigates the mechanisms behind this process and the evolution of these defenses. By studying the roles of various bacterial and viral proteins, the lab aims to enhance our understanding of bacterial immunity and develop potential therapeutic strategies like phage therapy for treating bacterial infections.

Professor Andrea Soranno's lab at Washington University focuses on understanding the molecular mechanisms of SARS-CoV-2, specifically how its nucleocapsid protein packages the viral genome. By employing techniques like single-molecule fluorescence and force spectroscopy, the lab aims to reveal the biophysical interactions that drive genome compaction, which is crucial for the virus's life cycle. Their work not only seeks to explain how coronaviruses function but also to identify potential therapeutic agents that could disrupt these processes.

Dr. Sean Pj Whelan's lab at Washington University focuses on understanding how SARS-CoV-2, the virus responsible for COVID-19, enters cells and how to block this process to develop effective therapeutics. The lab employs advanced imaging techniques and genetic screening to map the viral entry pathways and identify host proteins that the virus hijacks during infection. Their research aims to uncover new therapeutic targets while also evaluating the effectiveness of current clinical interventions against the virus.

Dr. Andrei G. Vlassenko's research focuses on understanding brain metabolism, especially as it relates to aging and Alzheimer's disease. His lab uses advanced imaging techniques, like PET and MRI, to explore how the brain uses oxygen and glucose during mental tasks, and how this might change in older adults and those with cognitive impairments. The goal is to uncover the metabolic processes involved in brain health and disease, which could lead to new insights on preventing cognitive decline.

Dr. Xiaoxiao Wan's lab at Washington University explores how certain molecules in pancreatic beta cells can trigger autoimmunity, specifically in type 1 diabetes. The lab focuses on understanding neoepitopes—modified pieces of proteins that can provoke harmful immune responses. By studying how these neoepitopes are formed and their role in autoimmune diseases, particularly type 1 diabetes, the lab aims to identify new targets for potential therapies and improve our understanding of disease mechanisms.

Dr. Christine O'Brien's lab works on developing innovative wearable devices that can help monitor blood loss during childbirth, specifically aiming to address postpartum hemorrhage (PPH). By creating technologies that non-invasively measure important cardiovascular parameters, the lab seeks to provide early detection of PPH, which is crucial for improving patient outcomes and reducing maternal mortality. The research combines biomedical engineering and real-world clinical applications to enhance maternal health.

Dr. Krista Milich's lab focuses on understanding how diseases spill over from wildlife to humans, particularly looking at viral transmission dynamics in red colobus monkeys in Uganda. By studying the interactions between these monkeys and local human populations, her team gathers important ecological data to predict and model disease spread. This research aims to improve public health outcomes and advance conservation efforts while providing educational opportunities for students both in the U.S. and Uganda.

Dr. Pamela K Woodard's lab focuses on understanding carotid artery diseases, specifically atherosclerosis, which can lead to strokes. Using advanced PET imaging techniques, the research aims to differentiate between patients at high risk of plaque rupture and those who may not need surgical intervention. By studying specific molecular markers in patients, the lab hopes to improve treatment strategies and reduce unnecessary healthcare costs.

Dr. Dmitriy A. Yablonskiy's research lab focuses on developing advanced MRI techniques to improve the early detection of Alzheimer's Disease and its progression. The lab is working on a novel MRI method called Deep-Learning-Augmented quantitative Gradient Recalled Echo (DLA-qGRE), which allows for better identification of brain microstructural changes associated with neurodegeneration before significant symptoms appear. This work aims to create efficient, non-invasive diagnostic tools that can help monitor Alzheimer's and other neurodegenerative conditions.